In:
JAMA Oncology, American Medical Association (AMA), Vol. 9, No. 8 ( 2023-08-01), p. 1144-
Abstract:
This systematic review investigates how often and to what extent primary end points are changed and reported in immune checkpoint inhibitor clinical trials.
Type of Medium:
Online Resource
ISSN:
2374-2437
DOI:
10.1001/jamaoncol.2023.1374
Language:
English
Publisher:
American Medical Association (AMA)
Publication Date:
2023
Permalink